WallStreetZen

NYSE: EVH
Evolent Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for EVH

Based on 3 analysts offering 12 month price targets for Evolent Health Inc.
Min Forecast
$20.00-24.1%
Avg Forecast
$23.67-10.18%
Max Forecast
$27.00+2.47%

Should I buy or sell EVH stock?

Based on 3 analysts offering ratings for Evolent Health Inc.
Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

EVH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Canaccord Genuity
Top 24%
77
Strong BuyMaintains$27.00+2.47%2021-08-05
Anonymous
Canaccord Genuity
Strong BuyMaintains$24.00-8.92%2021-03-01
BTIG
Top 39%
62
Strong BuyInitiates Coverage On$20.00-24.10%2021-01-07

1 of 1

Forecast return on equity

Is EVH forecast to generate an efficient return?
Company
-1.85%
Industry
12.31%
Market
60.49%
EVH's Return on Equity is forecast to be low in 3 years (-1.85%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is EVH forecast to generate an efficient return on assets?
Company
-0.88%
Industry
7.14%
Market
16.9%
EVH is forecast to generate lower Return on Assets (-0.88%) than the US Health Information Services industry average (7.14%)
Forecast

EVH earnings per share forecast

What is EVH's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$0.27-63.85%
Avg 2 year Forecast
-$0.15-80.41%
Avg 3 year Forecast
-$0.13-82.43%

EVH revenue forecast

What is EVH's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$888.4M-8.76%
Avg 2 year Forecast
$1.0B+5.1%
Avg 3 year Forecast
$1.2B+22.32%
EVH's revenue is forecast to grow at a rate of 2.93% per year, which is not exceptional
Forecast

EVH revenue growth forecast

How is EVH forecast to perform vs Health Information Services companies and vs the US market?
Company
2.93%
Industry
15.67%
Market
14.3%
EVH's revenues are forecast to grow slower (2.93% per year) than the US Health Information Services industry average (15.67%)
Forecast
EVH's revenues are forecast to grow slower (2.93% per year) than the US market average (14.3%)
Forecast

Evolent Health Stock Forecast FAQ

Is Evolent Health Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NYSE: EVH) stock is to Strong Buy EVH stock.

Out of 3 analysts, 3 (100%) are recommending EVH as a Strong Buy, 0 (0%) are recommending EVH as a Buy, 0 (0%) are recommending EVH as a Hold, 0 (0%) are recommending EVH as a Sell, and 0 (0%) are recommending EVH as a Strong Sell.

What is EVH's earnings growth forecast for 2021-2023?

(NYSE: EVH) Evolent Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 27.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 23.36%.

Evolent Health's earnings in 2021 is -$70,887,000.On average, 4 Wall Street analysts forecast EVH's earnings for 2021 to be $-23,344,129, with the lowest EVH earnings forecast at $-24,434,976, and the highest EVH earnings forecast at $-21,816,943. On average, 4 Wall Street analysts forecast EVH's earnings for 2022 to be $-12,653,827, with the lowest EVH earnings forecast at $-24,434,976, and the highest EVH earnings forecast at $-2,618,033.

In 2023, EVH is forecast to generate $-11,344,810 in earnings, with the lowest earnings forecast at $-11,344,810 and the highest earnings forecast at $-11,344,810.

What is EVH's revenue growth forecast for 2021-2023?

(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 2.93% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 15.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.3%.

Evolent Health's revenue in 2021 is $973,644,000.On average, 3 Wall Street analysts forecast EVH's revenue for 2021 to be $77,526,594,218, with the lowest EVH revenue forecast at $77,101,076,562, and the highest EVH revenue forecast at $78,299,263,072. On average, 3 Wall Street analysts forecast EVH's revenue for 2022 to be $89,298,493,054, with the lowest EVH revenue forecast at $87,128,143,565, and the highest EVH revenue forecast at $91,109,299,323.

In 2023, EVH is forecast to generate $103,935,916,452 in revenue, with the lowest revenue forecast at $103,935,916,452 and the highest revenue forecast at $103,935,916,452.

What is EVH's forecast return on assets (ROA) for 2021-2023?

(NYSE: EVH) forecast ROA is -0.88%, which is lower than the forecast US Health Information Services industry average of 7.14%.

What is EVH's Price Target?

According to 3 Wall Street analysts that have issued a 1 year EVH price target, the average EVH price target is $23.67, with the highest EVH stock price forecast at $27.00 and the lowest EVH stock price forecast at $20.00.

On average, Wall Street analysts predict that Evolent Health's share price could stay at $23.67 by Aug 5, 2022. The average Evolent Health stock price prediction forecasts a potential downside of N/A from the current EVH share price of $26.35.

What is EVH's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: EVH) Evolent Health's current Earnings Per Share (EPS) is -$0.74. On average, analysts forecast that EVH's EPS will be $-0.27 for 2021, with the lowest EPS forecast at $-0.28, and the highest EPS forecast at $-0.25. On average, analysts forecast that EVH's EPS will be $-0.15 for 2022, with the lowest EPS forecast at $-0.28, and the highest EPS forecast at $-0.03. In 2023, EVH's EPS is forecast to hit $-0.13 (min: $-0.13, max: $-0.13).

What is EVH's forecast return on equity (ROE) for 2021-2023?

(NYSE: EVH) forecast ROE is -1.85%, which is considered weak.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.